Media stories about Innocoll (NASDAQ:INNL) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innocoll earned a news impact score of 0.09 on Accern’s scale. Accern also assigned media headlines about the specialty pharmaceutical company an impact score of 44.7469577023245 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Innocoll (INNL) opened at $2.35 on Friday. The company has a debt-to-equity ratio of -2.26, a quick ratio of 0.86 and a current ratio of 1.01. The stock has a market cap of $70.73 and a PE ratio of -1.42. Innocoll has a 12-month low of $0.53 and a 12-month high of $6.51.
TRADEMARK VIOLATION NOTICE: “Innocoll (INNL) Receiving Somewhat Positive Media Coverage, Report Finds” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/14/innocoll-innl-earns-coverage-optimism-rating-of-0-09.html.
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Ratings for Innocoll Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll and related companies with MarketBeat.com's FREE daily email newsletter.